Information contained in the European Union (EU) Clinical Trials Register managed by the European Medicines Agency EMA is now also available through the WHO International Clinical Trial Registry Platform (ICTRP).

This follows recognition by the World Health Organization (WHO) in September 2011 of the EU Clinical Trials Register as one of the 'primary registries' for the ICTRP. The WHO and EMA have worked together in developing the technical processes to allow data transfer from the EU Clinical Trials Register to ICTRP.

ICTRP is a web-based portal that allows access to a wide range of information from different clinical-trial registers from across the world. Primary registries meet specific criteria for content, quality, validity and transparency. Recognition as a primary registry is an endorsement of the importance of the EU Clinical Trials Register for potential clinical trial participants as well as sponsors, researchers, ethics committees and policymakers.

The availability of the register on the WHO ICTRP platform provides wider access to the information contained in the registry and contributes to the dissemination of information related to authorised clinical trials for use by the scientific community and the public.

Source: EMA Press Release

Related GMP News
06/03/2013	ICH publishes New Draft Guideline on Genotoxic Impurities
14/02/2013	New EU Template for QP Declaration (IMPs)
14/02/2013	New Eudralex Vol.10 Guidance
14/02/2013	EMA issues Concept Paper for Antimicrobial Resistance Risk Assessment Guideline
14/02/2013	Responses to the public Consultation on the Paediatric Regulation